- Home
- Services
- asia middle east
- breast cancer with adjacent normal breast
Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Breast Cancer With Adjacent Normal Breast Services In Asia Middle East
5 services found
Manufactured by:Celemics, Inc. based inSeoul, SOUTH KOREA
Customized Targeted Sequencing. BRCA1,2 (Breast Cancer). OncoRisk. CancerScreen / CancerMaster. G-Mendeliome Clinical Exome Sequnecing. G-Mendeliome Disease Specific. Customized RNA Sequencing. Customized Methy;ation Sequencing. ctDNA (Colorectal, Lung, ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
AmpliMark is the foundational technology behind Lucence’s liquid biopsy tests. AmpliMark uses unique molecular barcodes in this error-correction technology. It is designed to improve detection of multiple mutation types like single nucleotide variants, insertions and deletions (indels), copy number variations (CNVs), fusions and microsatellite instability ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
The AlphaLiquid® platform is being widely applied in translational research to empower our understanding of tumor evolution, response to therapy and resistance mechanisms, as well as to provide insights on the clinical value of ctDNA analysis in precision ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
by:Burning Rock Biotech Limited based inGuangzhou, CHINA
Cancer is a complicated disease caused by genetic variation. The genetic variation may deprive cells of the normal control function, leading to immortalization and cancer. And targeted drugs work well in cancer therapy, which can kill cancer cells that carry specific genes of variation. However, patients may differ from each other regarding the in vivo genetic variation. As a result, patients ...